Regenerative Medical Technology (RMTG) Receivables - Net (2021 - 2025)
Historic Receivables - Net for Regenerative Medical Technology (RMTG) over the last 5 years, with Q3 2025 value amounting to $114006.0.
- Regenerative Medical Technology's Receivables - Net rose 26769.01% to $114006.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $114006.0, marking a year-over-year increase of 26769.01%. This contributed to the annual value of $22605.0 for FY2024, which is 563.95% down from last year.
- Regenerative Medical Technology's Receivables - Net amounted to $114006.0 in Q3 2025, which was up 26769.01% from $36676.0 recorded in Q2 2025.
- Regenerative Medical Technology's Receivables - Net's 5-year high stood at $250000.0 during Q2 2021, with a 5-year trough of $16306.0 in Q1 2025.
- In the last 5 years, Regenerative Medical Technology's Receivables - Net had a median value of $36676.0 in 2025 and averaged $55304.9.
- Per our database at Business Quant, Regenerative Medical Technology's Receivables - Net crashed by 9078.92% in 2022 and then surged by 26769.01% in 2025.
- Quarter analysis of 5 years shows Regenerative Medical Technology's Receivables - Net stood at $17256.0 in 2021, then skyrocketed by 188.4% to $49766.0 in 2022, then crashed by 51.86% to $23956.0 in 2023, then decreased by 5.64% to $22605.0 in 2024, then skyrocketed by 404.34% to $114006.0 in 2025.
- Its Receivables - Net stands at $114006.0 for Q3 2025, versus $36676.0 for Q2 2025 and $16306.0 for Q1 2025.